Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$168,567,906
+$90,326,752 QoQ
Shares Held
140,540
+65.2% QoQ
Ownership
0.015%
of shares outstanding
% of Portfolio
0.25%
of 13F equity value
Holder Rank
#289
of 4,605 holders
Holding Since
Jun 2022
17 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BAMCO INC /NY/ holds $189,132,430 across 5 Drug Manufacturers - General names. LLY ranks #1 (89.1% of the industry book) .
All Filings in LLY
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $168,567,906 | 140,540 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $78,241,154 | 85,066 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $92,934,036 | 86,476 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $65,322,719 | 85,613 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $76,892,059 | 98,639 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $27,126,188 | 32,844 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,440,000 | 20,000 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $20,376,620 | 23,000 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $21,729,120 | 24,000 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $20,226,960 | 26,000 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $20,164,368 | 34,592 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $18,580,400 | 34,592 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $16,222,956 | 34,592 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $11,879,584 | 34,592 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $12,655,137 | 34,592 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $10,635,628 | 32,892 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $10,372,766 | 31,992 | Shares | Defined | 2022-08-15 | |
| No filing history on record for this holder in this stock. | ||||||